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Introduction
E
urope has a long tradition of preventing disease and
prolonging life expectancy through organized public health
interventions. Nevertheless, considerable challenges remain
in a European Union that permits free movement of goods,
services, money and people. While pathogens travel freely
across borders, national control measures do so to a lesser
extent. Thus, public health is hampered by societal, economic,
financial and cultural differences and suboptimal collaboration
between responsible agencies. These challenges became initially
apparent during the SARS emergency and subsequently during
the avian influenza threat that drew a lot of media attention.
With the foresight to enhance preparedness and response
to communicable disease threats the European Union
created a specialized agency in Stockholm, Sweden. This new
EU agency, the European Centre for Disease Prevention and
Control (ECDC), has the mandate to control communicable
diseases in Europe. Since the existing measures were
inadequate to deal with multi-country outbreaks, ECDC
strives to assess the risk to Member States. This effort can be
enhanced through collaboration and networking between
European public health practitioners.
ECDC has been operational since May 2005 and although
still relatively small (151 staff members as of February 2008),
the organization is rapidly growing. ECDC, according to its
mission
1 and under the guidance of its Management Board
and Advisory Forum, has focused on developing an integrated
surveillance system for the EU, setting up a system for rapid
response to outbreaks and epidemics, establishing a unit for
health communications and scientific advice (figure 1). The
latter provides independent scientific opinions, expert advice,
data and information on pertinent public health issues in
Europe and leads an initiative on climate change and migrant
health. The Health Communication Unit is responsible for
communicating the scientific and technical outputs of the
Centre to European health professionals and to the general
European public, as well as supporting the Member States on
communications activities. The Preparedness and Response
Unit monitors emerging threats in Europe, and supports EU
Member States in assessing, investigating and responding to
them. The Unit relies on a set of advanced information tech-
nology tools to detect potential threats, with special attention
to events threatening more than one EU Member State. One
of the main tasks of the Surveillance Unit is to integrate the
operations of the 17 EU-wide surveillance networks (e.g.
Enter-net, EuroHIV, EuroTB, etc) into ECDC. These networks
are called ‘dedicated surveillance networks’, DSNs, with the
aim to provide easy access to descriptive data on communi-
cable diseases and to facilitate monitoring and comparison of
incidence trends in the EU Member States.
The timeliness of a coordinated effort in communicable
disease control in Europe is undisputed, and the recent out-
break of avian influenza illustrated the ability of the ECDC to
rapidly respond to emerging communicable disease threats: the
Centre responded (and is trying to continuously respond) to
the needs of the EU Member States with regards to daily
situation updates, risk assessments and suggested coordinated
actions. Such efforts are not only needed for influenza pre-
paredness but also other communicable diseases and health
issues such as HIV, vaccine-preventable diseases, anti-micro-
bial resistance, etc. These disease-specific programmes lie
horizontal in the organizational matrix of ECDC (figure 1).
A coordinated approach to communicable diseases clearly
adds value to public health in Europe. While communicable
disease mortality has been dramatically pushed back over the
last century, communicable diseases remain a health threat
especially in certain regions, subpopulations or during certain
seasons. Emerging communicable diseases are of particular
concern such as SARS, new influenza strains, Chikungunya,
etc.
2 Tuberculosis, particularly the multiple and extensively
drug resistant forms, is a growing problem across the region.
Trans-national coordination of vaccine schedule integration is
another task that can only be addressed through a collaborative,
international approach. National vaccine schedules do not lend
themselves to be moved across borders, while their recipients
can.
3 Furthermore, evidence-based decision making is the cor-
nerstone for effective public health policy but relies on prudent
evaluation of large-scale interventions.
4 Guideline development
and adaptation is best done collaboratively, taking into account
different settings and circumstances. This short list of public
health predicaments are amenable to improvement through
European collaboration and networking.
Since the mandate of the ECDC is to protect human health
from communicable diseases through theprevention and control of
human disease and to ensure comprehensiveness, coherence and
complementarity of action a strategy is proposed here. We pres-
ent a long-term framework to advance public health in Europe
through networking and cooperation between associations,
federations, societies and organizations. Such an effort will
ensure comprehensiveness, coherence and complementarity of
public health action in Europe. This initiative goes beyond the
current governance structure of ECDC, since this network will
not rely on representatives from national agencies or individual
Member States but rather from Europe-wide health organiza-
tions. Thus, this initiative will complement current initiatives
and strengthen European public health at large.
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Pan-European public health associations, federations, societies
and organizations were identified through systematic web
searches, outreach to researchers, scientists, public health
practitioners and ECDC staff. However, important associa-
tions, federations, societies and organizations might have been
missed despite this extensive search. A pre-meeting ques-
tionnaire with 15 questions pertaining to public health prior-
ities and activities was mailed to the scientific organizations
and subjected to content analysis. The questionnaire addressed
the following questions: What is your main area of work? What
do you consider the most important public health issues in
your particular field of interest? What are your top 4 action
priorities? Please list the main meetings or projects your
organization is involved with. What further support or capac-
ity would your organization need to address these issues? With
what other organizations are you currently collaborating?
Please name key European experts/spokespeople in your field.
Please identify potential areas of collaboration between your
organization and ECDC. How many organizations belong to
your association? In which EU Member States and beyond is
your organization operational? What is your annual budget
(in Euros)? Do you have your own website? Do you publish a
regular newsletter? How many press releases were issued by
your organization last year? What health/environment infor-
mation or news websites do you access regularly?
A workshop was convened at ECDC on 27–28 February
2007 in Stockholm with the task to identify public health gaps
and potential solutions to these deficiencies. ECDC and work-
shop participants presented their work and highlighted the
public health priorities in their respective fields. This analysis is
based on the result of the questionnaire survey and group
discussions held at the workshop.
Results
Twenty-one scientific organizations were identified and
contacted (table 1). A questionnaire was sent to all 21 scientific
organizations and 19 responses were obtained (participation
rate 91%). They represented a wide range of specializations,
including virology, respiratory diseases, microbiology, geno-
mics and health management. The organizations were very
diverse in terms of their size, structure, membership and capac-
ity. Some smaller organizations consisted of individuals only
with no central office, relying on volunteer input and focusing
on exchange of information and data. Other societies were
extensive networks of national organizations (range 1–390
organizations) and belonged to global bodies. A few well
established societies had annual budgets >1 million Euros
(range 50000 to >1 million Euros), large staff teams and con-
ferences that brought together tens of thousands of delegates.
Some of these societies were leaders in improving the quality
standards of their profession, worked closely with regulators,
published reputable journals and undertook cutting edge
research. While the organizations varied in many ways, they
all had a broad European-wide mandate and membership and
shared many public health action priorities, particularly in the
areaofcommunicable disease surveillanceandcontrol (table1).
These 21 organizations were convened to form a Scientific
Consultation Group (SCG) with the goal to strengthen
ECDC’s sources of public health intelligence and expertise in
Europe as well as to explore the potential for cooperative
activities between ECDC and these organizations and between
the organizations themselves. The SCG is conceived as one key
strategic way of helping ECDC address its mandate to foster
comprehensiveness, coherence and complementarity of action
on communicable diseases in Europe. Many shared common
challenges and ways to overcome them were identified; includ-
ing, advancing cross-border integration, promoting evidenced-
based practice and addressing key public health challenges.
Addressing public health concerns
The scientific organizations identified a broad range of public
health concerns and priorities for action, including human
resources, public information, laboratory competence, anti-
microbial resistance, vaccine availability, patient safety, surveil-
lance and response to communicable diseases that are listed in
table 1. The most important public health issues identified by
individual organizations is naturally linked to their specific
field of interest, but some cross cutting topics became apparent
such as anti-microbial resistance. Action points on how to
respond to these health concerns is also grouped by association
and is listed in table 1.
Director and Director’s Cabinet
Governance, Management,
External Relations, Country Cooperation
Scientific
Advice
Surveillance Preparedness &
Response
Administrative
Services
Influenza
Tuberculosis
Food-& waterborne diseases
Other diseases of environmental & zoonotic origin
Vaccine-preventable diseases & invasive bacterial infections
HIV, STI & blood-borne viruses
Antimicrobial resistance & healthcare-related infections
Health
Communication
Figure 1 European Centre for Disease Prevention and Control (ECDC) Organogram
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Advancing cross-border integration
All participating organizations operated on a European level,
some of them exclusively some not, and faced the challenge of
overcoming national barriers with their cultural, economic and
health system diversity. These intricacies seem to be more
apparent along the east–west and north–south gradient of
Europe. Networking and promoting cooperation among their
member organizations were seen as a way of overcoming
national particularities. For example, European vaccination
schedules lack concordance, and because they are not easily
Table 1 Pan-European organizations and their public health priorities, 2007
Organization Main area of work Most important public health issues
in field of interest
Top 4 action priorities
European Academies
Science Advisory Council
(EASAC)
EASAC covers all scientific and tech-
nical disciplines, enabling science
academies to collaborate to provide
advice to policy-makers.
1. Vaccine innovation and vaccina-
tion strategies
2. Tackling AMR
3. Zoonoses—public health issues
and R&D gaps
Migration and IDs
European Biosafety
Association (EBSA)
Biosafety and biosecurity 1. Adequate biorisk management
2. Competence of those responsible
for biosafety
1. CEN laboratory standard initiative
2. Funding for CEN standard
initiative on biosafety officer
competence
European Federation for
Medical Informatics
(EFMI)
Health data, knowledge and infor-
mation, health information systems,
web portal, two annual conferences,
standardization of data and knowl-
edge, security, privacy
1. Good quality data and knowedge
2. Deriving data from routine data,
e.g. hospital information systems
3. Defining standards for public
health information systems
1. Data and knowledge acquisition
2. Information and training
3. Standardization of data
European Federation of
Parasitologists
Promotion of scientific research and
training in parasitology in Europe
through the organization of meet-
ings and diffusion of information
about research grants in this field.
1. Malaria and Schistosomiasis
2. Leishmaniasis, Trypanosomiases,
Filariases, Onchocerciasis
3. All other important human para-
sitic diseases
1. Parasitology societies in European
countries
2. Organization of international
scientific events
3. Diffusion of information about
news in parasitology
4. Supranational agencies related to
parasitology and parasitic diseases
European Health
Management Association
(EHMA)
Our work focuses on health man-
agement and those issues that touch
upon the health of European citizens
and the delivery of health services
throughout Europe.
1. Improving quality and safety in
healthcare
2. Reducing health inequalities
3. Improving efficiency and effec-
tiveness of healthcare delivery
European Public Health
Association (EUPHA)
To be the pro-active platform for
information exchange between
public health research, practice and
policy on a European level.
1. Information exchange between
countries
2. Information exchange between
different disciplines
3. Information exchange between
research, policy and practice
1. Health inequalities in European
countries
2. Health inequalities between
countries in Europe
3. Obesity epidemic
4. Public health capacity building
European Respiratory
Society (ERS)
The ERS covers all aspects of respira-
tory diseases, both in children and
adults, including asthma, COPD,
respiratory infections, interstitial
lung diseases, cystic fibrosis, lung
cancer and lung transplants, etc.
1. COPD
2. Asthma
3. Respiratory infections
1. COPD
2. Asthma
3. Respiratory infections
4. Lung cancer
European Science
Foundation (ESF) –
European Medical
Research Councils (EMRC)
EMRC is the membership organiza-
tion of the Medical Research Councils
in Europe and promotes innovative
medical research and its clinical
applications towards improved
human health.
1. Basic science, translational and
clinical research
2. Population surveys and biobank-
ing—for understanding etiology,
patho-physiology, clinical and
preventive aspects of ID, emerging
diseases and life-style-related
diseases
1. Foresight
2. Science policy briefings studies
3. Research conferences
4. Young investigators awards
European Society for
Clinical Investigation
(ESCI)
ESCI organizes annual scientific con-
ferences and workshops, and pub-
lishes the European Journal of
Clinical Investigation, a journal of
molecular and clinical
pathophysiology.
1. Cardiovascular, gastroenterologi-
cal and liver diseases
2. Infections and disorders of immu-
nity
3. Metabolic and endocrine disorders
1. Organizing high-quality, multi-
disciplinary medical meetings
2. Publishing a multi-disciplinary
journal of mechanisms of disease
3. Providing the annual ESCI Award
for Excellence in Clinical Science
European Society of
Clinical Microbiology and
Infectious Diseases
(ESCMID)
Promote and support research, edu-
cation and training in the infection
disciplines by scientific exchange,
educational programmes, grants and
awards, certification and consulta-
tion with professional and govern-
ment agencies.
1. Overcome AMR
2. Reduce healthcare-associated
infection
3. Develop vaccines against the main
‘scourges of mankind’ (malaria,
HIV, etc)
1. Disseminate knowledge (journal,
meetings)
2. Provide post-graduate training
and education
3. Convene study groups on specific
issues
4. Foster dialogue between
professional organizations
(continued)
A public head network strategy 443transferable to a different country they might collide with best
practices. EUVAC-NET (http://www.ssi.dk/euvac/vaccination/
vaccination.html) data on childhood immunization schedules
reveal that the number of dose for both anti-tetanus and
diphtheria vaccine can range from 4 to 8 doses, based on
country of residence; similarly, 12 European countries use
acellular pertussis vaccines, while 9 countries use cellular
vaccines and 9 use both (Dr P. L. Lopalco, personal commu-
nication). Thus, a collaborative approach to gather and deliver
scientific opinions on the integration of vaccination schedules
was recognized as a useful goal. A solution could range from
a minimal approach of advising families on how to switch
between immunization schedules if they are moving around
within the EU to a comprehensive proposal for integration of
vaccination schedules.
Another cross border problem is the recent outbreaks of
Chikungunya fever. Chikungunya fever is a mosquito-borne
viral disease with symptoms such as fever, joint pain, muscle
pain, headache and nose and gum bleeding. Chikungunya
is endemic in parts of Africa, Southeast Asia and on the
Indian subcontinent. Very large outbreaks have been reported
from La Re ´union, Mauritius, Mayotte and several Indian states
Table 1 Continued
Organization Main area of work Most important public health issues
in field of interest
Top 4 action priorities
ESCMID Study Groups –
ESGNI, ESGEM, ESGAP
Healthcare-associated infections
(HAI) – surveillance, audit, review
and design of policies. Increasing
evidence for interventions. Several
workshops.
1. Consensus on clinical governance
framework and HAI prevention
and control.
2. Educational activities (extend to all
HCWs), ESCMID
3. Improve evidence base for effec-
tiveness of HCAI and AMRIX
interventions.
4. IT systems and HCAI
1. IPSE WP2—(HPA lead) national
priorities
2. IPSE WP1—Syllabus re curriculum
competencies
3. ARPAC FP6—improve evidence
base
4. Fill gaps in surveillance
European Society for
Clinical Virology (ESCV)
To bring together scientists and
clinicians throughout Europe and to
promote Public Health and advance
education, particularly medical edu-
cation, in Clinical and Basic Virology
1. Appropriate viral laboratory diag-
nostics including quality control
2. Appropriate clinical interpretation
of viral diagnostics
3. Appropriate treatment and pre-
vention of viral diseases
1. Educational meetings in clinical
virology
2. Participation in European QC
activities
3. Promotion of research in the field
4. Grants and awards to stimulate
students
European Society for
Paediatric Gastro-enterol-
ogy, Hepatology &
Nutrition (ESPGHAN)
Paediatric gastroenterology, hepa-
tology and nutrition, both clinical
and research-Driven activities.
Promoting knowledge of paediatric
gastroenterology, hepatology and
clinical nutrition, stimulating
research in these fields and dissemi-
nating such knowledge.
1. Undernutrition and obesity in
children
2. Policies for infant nutrition
3. Vaccination for gut and liver
infections
1. Preparation of guidelines for
infant nutrition
2. Education programmes for pae-
diatric gastroenterology, hepatol-
ogy and nutrition in Europe
3. Promoting research in paediatric
gastroenterology, hepatology and
nutrition
European Sociological
Association
Raising the level of awareness of
sociology of health in European
contexts.
1. Imparting sociological knowledge
and awareness of PH
2. Working with PH officials on
various key health issues in Europe
3. Making an impact on medical
education with regards to
sociology
1. Education of professionals
2. Imparting knowledge
3. Networking with others in the
health field
4. Raising sociological awareness
in PH
Federation of European
Microbio-logical Societies
(FEMS)
FEMS main mission is to advance and
unify microbiology knowledge. FEMS
brings together 46 member societies
from 36 European countries, cover-
ing over 30000 microbiologists.
1. FEMS considers all aspects of
microbiology, including health
issues
2. Infectious diseases
3. Food-related infectious diseases
1. Publishing five journals
2. Financial support to young scien-
tists
3. Financial support for meetings
4. European congress organization
Federation of European
Societies for
Chemotherapy and for
Infections (FESCI)
Anti-microbial chemotherapy,
Infectious diseases
1. Antibiotic resistance
2. Antibiotic misuse
3. Infection control
Federation of European
Societies for Tropical
Medicine & International
Health
Tropical medicine and international
health
1. Human resource crisis
2. Access to health care, inequity
3. Research (HSR)
1. Platform and advocacy
2. Scientific improvement
3. Education
International Society of
Chemotherapy
Clinical microbiology, infectious
diseases, AMR
1. Antibiotic resistance
2. Antibiotic misuse
3. Infection control
Public Health Genomics
European
Network(PHGEN), run by
Institute of Public Health
NRW (lo ¨gd)
Working towards the responsible
and effective translation of genome-
based knowledge and technologies
into public policy and into health
services for the benefit of population
health.
1. Informing public policy with
regards to Genomics and PH
2. Health Service Development and
Evaluation
3. Training the workforce and edu-
cating the public
1. Advising the EC
2. Initializing National Task Forces on
PH Genomics in all 31 PHGEN
member states
3. Identification of legal diversities
and barriers in Europe (with
regard to cross- border
market, e.g.)
4. Conducting networking exercise in
this field
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several European countries. ECDC convened a group of scien-
tific experts from a number of organizations and generated
a rapid risk assessment tool that Member States could use for
their own planning. More recently, indigenous transmission
of Chikungunya was reported in North-East Italy where Aedes
mosquitoes are established, which poses threats to other
regions of Europe where the vector is present.
5–8 Transmission
and dispersion in temperate countries of Europe of this and
other tropical diseases (e.g. Dengue) in the coming years must
be considered.
9,10 A collaborative approach by these organiza-
tions can not only help in developing and disseminating
guidelines like the Chikungunya rapid risk assessment tool but
also in assisting implementation of recommended actions
through their membership across the region.
Advancing evidence-based public health
in Europe
One challenge reported by most of the organizations is to find
ways to integrate clinical and public health practices with
evidence-based guidelines and data sets; examples include:
– Authoritative endorsement/complementary dissemination
of guidelines produced by expert groups.
– Data standardization and integration.
– Medical guideline reviews.
– Expert advice on guidelines, surveillance, interventions.
– Develop extensive networks for consultation and peer review.
– Deliver a range of documents adapted to different
readerships.
– Monitoring the implementation of guidelines.
– Informing ECDC ‘Standard Operating Procedures’.
– Working towards interventions/standardization of profes-
sional interventions.
As these fall outside EU competence, working through national
scientific bodies allows for a potential independent Pan-
European Scientific community source of integration. Most
organizations issue some sort of scientific, research, public
and/or clinical guidance. Some extend their opinions to social
marketing and policy advocacy work.
These organizations support progress in medical treatment
through rigorous evaluation and application of existing
medical evidence; in fact, prudent use of systematic reviews
of research findings from randomized, blinded trials is the
cornerstone of ‘do no harm’.
11,12 While integration of research
findings within public health practice yields the best possible
population health, scientific evidence can collide with political,
social, business, advocacy, religious or ideological groups.
13
Networking among these scientific organizations was identified
as one way of overcoming these hurdles and promoting
evidence-based practice.
The need for the development and dissemination of guidance
on issuing guidance was also identified as a need. A potential
role for ECDC in authoritative endorsement of guidelines was
noted. This was felt to be particularly important for smaller
Member States as they look to ECDC for guidelines while larger
countries might already have developed their own policies.
Networking for public health problem solving
The foundations of successful networking that were identified
during the ECDC workshop included mutual benefit, trust and
respect. All partners need to work towards the achievement of
shared goals. The participants emphasized that networks are
essentially relationships that need champions and are often
based on personal connections. But sustainable partnerships
move beyond individuals. Relationships should be built on
clear rules, such as a Memorandum of Understanding or
standard operating procedures and be subject to regular
review.
Making the case for such partnerships through evidence is
important: for example, it was recognized that it is easier to
achieve goals through collaboration. Capacity building and
mentoring are core elements in networking. Networks can
provide visibility but the benefits have to overcome the
barriers.
14 Twinning can be a good example, through mutual
interest in a specific topic and investment in the relationship
by lots of visits, interactions. Networking needs to deliver
useful outputs and continue to deliver.
A minimum pre-condition is a shared vision, and this
may be created by complementary or similar organizations.
Partnerships may be goal- or objective-driven. Organizations
often look to partners to provide ‘missing’ skills or expertise
that they need in order to attain their goals.
Limitations and obstacles to inter-association
cooperation
A considerable challenge is the inherent difference between
partner organizations but also between Member States. These
differences can be significant, particularly when it comes to the
nature of public health practice. Reasons for this discrepancy
may be historic or cultural but could also be due to disparities
in capacity or resources. Financing is both an opportunity for
partnershipandathreatthatcanunbalancepartnerships.Power
struggles can emerge, and it is important to respect different
realities. Other obstacles include competing interests, competi-
tion between partners, limited resources, aspiration for
influence, autonomy and incompatibility of political or ethical
issues, e.g. regarding genomics. These obstacles have to be
recognized and dealt with proactively.
Next steps
Based upon the findings of the survey and workshop, ECDC has
established the SCG. It is now exploring not only ways to best
utilize its input to address its own mandate but also ways to
facilitate the capacity of the network to assist the organizations
and public health more broadly. To this end a fractal organo-
gramm was conceived for the SCG, with a core group of
members representing individual organizations, which in turn
represent other national organizations and their members
(figure 2). Fundamental and indispensable public health func-
tions,necessarytomeetpublichealthgoalshavebeenpreviously
described.
15,16 These activities address health determinants
17,
protect population health and treat disease and should be
adjusted to meet European public health goals. They include:
 Monitoring of health indicators through surveillance.
 Problem identification through assessment, investigation
and prediction.
 Inform, educate, empower through health education and
health promotion.
 Mobilize community partnerships and stakeholders.
 Develop health policies.
 Enforce laws and regulations.
 Access to health care.
 Assure a competent public health workforce.
 Evaluate effectiveness, accessibility and quality of public
health services.
 Public health research.
As part of the network strategy to advance public health in
Europe the SCG is placed at the centre of these public health
functions (figure 3), since it represents the numerous and
varied international partners involved in one or multiple of
these activities. The importance of building partnerships in
public health to overcome health challenges in Europe is
also recognized by the European Public Health Association
A public head network strategy 445(EUPHA). The fist action item of their 10 statements on the
future of public health in Europe calls for building essential
bridges between policy, practice and research and especially
between different disciplines.
18 Hence, the SCG will be con-
vened again by ECDC to explore this approach.
Conclusion
This article underscores the importance of networking among
scientific and advocacy organizations in order to meet the
increasing public health challenges of a unified Europe.
This analysis is based on a detailed survey of a large number
of Pan-European organizations and workshop discussion with
representatives from these organizations. It was concluded that
a range of practical ideas should be pursued for future
consideration. These included:
 cooperation in the development of standards and
guidelines.
 mutual assistance in professional and public educational
initiatives.
 working groups, conferences, publications and other
communications.
ESCV
ESCMID
ESCI
EMRC
ERS EUPHA
Other
EFMI
EBSA
EASAC
FEMS
Scientific
Consultation
Group
Scientific
Consultation
Group
 
Figure 2 Fractal organogramm of the SCG convened by ECDC, 2007. Representatives from pan-European public health
organisations are represented in the SCG, while these organizations in turn represent national organizations and other
stakeholders
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Figure 3 Ten essential public health functions with the SCG at the centre of core public health practice
446 European Journal of Public Health coordinated support for public, professional and political
advocacy of agreed public health issues.
 identification of research needs and priorities.
 active engagement in cooperative public health activities:
e.g. disease surveillance, public perception intelligence
gathering, programme evaluation and monitoring.
We believe that strengthening the SCG will not only improve
communicable disease control in Europe but also public health
in general.
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Key points
 Networking for public health among these organiza-
tions can advance many shared interests and common
mandates.
 The SCG as a whole is not vested in special or national
interests and can thus bring an additional voice to the
policy discourse.
 The SCG should aspire to strengthen essential public
health competencies in Europe.
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